Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

Author： Pardanani A. Hoffbrand A.V. Butterfield J.H. Tefferi A.

Publisher： Elsevier

ISSN： 0145-2126

Source： Leukemia Research, Vol.28, Iss.2, 2004-02, pp. : 127-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Minimal Residual Disease in Hairy-cell Leukemia after Treatment with 2-chlorodeoxyadenosine

By Konwalinka G. Schirmer M. Hilbe W. Fend F. Geisen F. Knoblechner A. Petzer A. Thaler J.

Blood Cells, Molecules, and Diseases, Vol. 21, Iss. 2, 1995-08 ,pp. : 142-151

Academic Press

Access to resources Recommend Favorite

Treatment of systemic mast cell disease: beyond interferon

By Tefferi A.

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 223-224

Elsevier

Access to resources Recommend Favorite

Systemic Mast Cell Disorders

By Meggs William J. Metcalfe Dean D.

Allergy and Asthma Proceedings, Vol. 5, Iss. 3, 1984-0 ,pp. : 226-230

OceanSide Publications, Inc

Access to resources Recommend Favorite

Mast Cell Disease

By Marney Samuel R.

Allergy and Asthma Proceedings, Vol. 13, Iss. 6, 1992-11 ,pp. : 303-310

OceanSide Publications, Inc

Access to resources Recommend Favorite

Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology

By Nieva J. Saven A.

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 113-114

Elsevier

Access to resources Recommend Favorite